ライフサイエンスコーパス: ventricular fibrillation

1 arrest or sustained ventricular tachycardia/ventricular fibrillation).

2 ricular arrhythmias (ventricular tachycardia/ventricular fibrillation).

3 ined or sustained ventricular tachycardia or ventricular fibrillation).

4 , hyperkalemia, or primary arrhythmia (i.e., ventricular fibrillation).

5 icular and papillary muscle VE that triggers ventricular fibrillation.

6 There were 2 procedural deaths related to ventricular fibrillation.

7 s and in patients with no baseline inducible ventricular fibrillation.

8 cation tools for SCD-ventricular tachycardia/ventricular fibrillation.

9 onnectivity that persists until the onset of ventricular fibrillation.

10 d to sudden cardiac arrest due to idiopathic ventricular fibrillation.

11 signals and a simulated patient experiencing ventricular fibrillation.

12 ignificant increase in response times to the ventricular fibrillation.

13 nin-angiotensin system (RAS), culminating in ventricular fibrillation.

14 an internal cardiac defibrillator shock for ventricular fibrillation.

15 n has focused on SCD-ventricular tachycardia/ventricular fibrillation.

16 am demonstrates continuous activities during ventricular fibrillation.

17 ad refractory ventricular tachycardia and/or ventricular fibrillation.

18 Late mortality was due to heart failure and ventricular fibrillation.

19 levels of CAR predispose to ischemia-induced ventricular fibrillation.

20 n was initiated after 6 minutes of untreated ventricular fibrillation.

21 surgery, 13.3% respiratory failure, and 8.4% ventricular fibrillation.

22 F hospitalization, HF death, and spontaneous ventricular fibrillation.

23 %) and 6 spontaneous ventricular tachycardia/ventricular fibrillation.

24 ence in dynamic properties between AF and VT/ventricular fibrillation.

25 termination of ventricular tachycardia (VT)/ventricular fibrillation.

26 ccessful appropriate ICD discharges were for ventricular fibrillation.

27 s of polymorphic ventricular tachycardia and ventricular fibrillation.

28 hmias due to Brugada syndrome and idiopathic ventricular fibrillation.

29 e submitted to coronary artery occlusion and ventricular fibrillation.

30 7.6% for all OHCA and 17.7% for OHCA due to ventricular fibrillation.

31 (ER) has recently been linked to idiopathic ventricular fibrillation.

32 h promotes the generation and maintenance of ventricular fibrillation.

33 receding ICD shocks distinguishes AF from VT/ventricular fibrillation.

34 ecular paradigm for some forms of idiopathic ventricular fibrillation.

35 urologic recovery after 15 mins of untreated ventricular fibrillation.

36 pacing at 200 and 300 beats per minute, and ventricular fibrillation.

37 under the most severe hemodynamic condition, ventricular fibrillation.

38 reduces induction of ventricular tachycardia/ventricular fibrillation.

39 after out-of-hospital cardiac arrest due to ventricular fibrillation.

40 eatment in patients with OHCA and refractory ventricular fibrillation.

41 0.05) compared with the baseline (untreated) ventricular fibrillation.

42 ventions terminating ventricular tachycardia/ventricular fibrillation.

43 ersion of induced ventricular tachycardia or ventricular fibrillation.

44 aventricular tachycardias converted to VT or ventricular fibrillation.

45 first recurrence of ventricular tachycardia/ventricular fibrillation.

46 ion MI, and 8.9% had ventricular tachycardia/ventricular fibrillation.

47 se (3 patients), or cardiac arrest caused by ventricular fibrillation (1 patient).

48 /day], intracranial haemorrhage [20 mg/day], ventricular fibrillation [120 mg/day], septic shock [80

49 ion of anesthesia and 7 minutes of untreated ventricular fibrillation, 16 female 3-month-old swine we

50 Protocol A: After 12 minutes of untreated ventricular fibrillation, 18 pigs were randomized to gro

51 atrial fibrillation (14 cases) and postictal ventricular fibrillation (3 cases).

52 ntricular block or complete heart block; (3) ventricular fibrillation; (4) ventricular tachycardia (>

53 st (14%), ventricular tachycardia (58%), and ventricular fibrillation (6%).

54 cation revealed shocks were delivered for VT/ventricular fibrillation (62%), AF (23%), and supraventr

55 AM patients (n = 123, 66%) more commonly had ventricular fibrillation (8 cases vs. 0 cases; p = 0.053

56 p < 0.001), had more ventricular tachycardia/ventricular fibrillation (81% vs 46%; p < 0.001), shorte

57 resuscitation (44% versus 25%; P=0.001) and ventricular fibrillation (84% versus 51%; P<0.0001).

58 often presented with ventricular tachycardia/ventricular fibrillation, a witnessed arrest, or had bys

59 ied out a study to compare response times to ventricular fibrillation across five patient loads: 16,

60 nts (60%) had ventricular tachycardia and/or ventricular fibrillation alternating with short periods

61 At 6 months, 1 patient in each group had ventricular fibrillation and 1 patient in each group die

62 4 and 17 seconds) for shocks that terminated ventricular fibrillation and 7 seconds (25th and 75th pe

63 ality is predicted by early recurrence of VT/ventricular fibrillation and ablation for electrical sto

64 iatric HCM proband with multiple episodes of ventricular fibrillation and aborted sudden cardiac deat

65 structural heart disease (mainly idiopathic ventricular fibrillation and Brugada syndrome) and in pa

66 ral highly dangerous heart diseases, such as ventricular fibrillation and congestive heart failure.

67 most episodes of ventricular tachycardia or ventricular fibrillation and decrease mortality in speci

68 of repetitive APs, leading in some cases to ventricular fibrillation and hemodynamic collapse in viv

69 nomic outflow significantly delayed terminal ventricular fibrillation and lengthened the duration of

70 ctrical activity in 874 children (84.8%) and ventricular fibrillation and pulseless ventricular tachy

71 ulseless electrical activity) and shockable (ventricular fibrillation and pulseless ventricular tachy

72 underwent 7 minutes of asphyxia followed by ventricular fibrillation and randomized treatment with e

73 quisite for aging-dependent QT prolongation, ventricular fibrillation and SCD immediately after trans

74 t uncalibrated dynamic patterns of Im during ventricular fibrillation and show that Im at singularity

75 Syndrome (LQTS) which increases the risk for ventricular fibrillation and sudden cardiac death.

76 an trigger reentrant arrhythmias, leading to ventricular fibrillation and sudden cardiac death.

77 its effectiveness in detecting and treating ventricular fibrillation and tachycardia.

78 lood flow were measured in seven pigs before ventricular fibrillation and then following 6 minutes of

79 val of patients resuscitated from near-fatal ventricular fibrillation and those with sustained ventri

80 ined as aborted cardiac arrest or documented ventricular fibrillation and ventricular tachycardia (la

81 ac alternans has been linked to the onset of ventricular fibrillation and ventricular tachycardia, le

82 th, ischemic stroke, ventricular tachycardia/ventricular fibrillation, and heart failure hospitalizat

83 ncluded acute respiratory distress syndrome, ventricular fibrillation, and hypotension.

84 senting rhythm of ventricular tachycardia or ventricular fibrillation, and lower S100B level.

85 ce of ventricular tachyarrhythmia, including ventricular fibrillation, and shock treatment was assess

86 laglutide 0.75 mg group); cardiogenic shock; ventricular fibrillation; and an unknown cause (n=3 in t

87 ntable cardioverter defibrillator shocks for ventricular fibrillation; and n=8 without implantable ca

88 After 10 minutes of untreated ventricular fibrillation, animals were randomized to thr

89 g per se, but may increase susceptibility to ventricular fibrillation) are found to be associated wit

90 26.1%, and 3.6% had ventricular tachycardia/ventricular fibrillation arrest.

91 of presentation with ventricular tachycardia/ventricular fibrillation as opposed to pulseless electri

92 pressure, and therapeutic hypothermia after ventricular fibrillation-associated cardiac arrest.

93 Patients with no inducible ventricular fibrillation at baseline were left on no the

94 DE, and right ventricular DE for death or VT/ventricular fibrillation at mean follow-up of 48 months

95 After 3 minutes of cardiac arrest (ventricular fibrillation at t = 0 min), animals were ran

96 icular beats and prevented fatal episodes of ventricular fibrillation, but did not prevent QT prolong

97 termination of rapid ventricular tachycardia/ventricular fibrillation can reasonably be considered an

98 (eg, induced hypothermia for out-of-hospital ventricular fibrillation cardiac arrest and birth asphyx

99 Resuscitation from ventricular fibrillation cardiac arrest and rigorous tem

100 Animals underwent 30-minute untreated ventricular fibrillation cardiac arrest followed by extr

101 minutes of cardiopulmonary resuscitation for ventricular fibrillation cardiac arrest improves short-t

102 diopulmonary resuscitation is feasible after ventricular fibrillation cardiac arrest in rats and impr

103 In a rat model of 6-minute ventricular fibrillation cardiac arrest, cardiopulmonary

104 e cerebral oxygenation and metabolism during ventricular fibrillation cardiac arrest, cardiopulmonary

105 After 6 minutes of ventricular fibrillation cardiac arrest, resuscitation w

106 ompared with guideline care in this model of ventricular fibrillation cardiac arrest.

107 prove 24-hour survival in a porcine model of ventricular fibrillation cardiac arrest.

108 mary effectiveness end point was the induced ventricular fibrillation conversion rate compared with a

109 s 99%, and sensitivity analysis of the acute ventricular fibrillation conversion rate was >90% in the

110 age impedance and system implant position on ventricular fibrillation conversion success with a subma

111 ssful conversion test required 2 consecutive ventricular fibrillation conversions at 65 J in either s

112 f 88%, with success defined as 2 consecutive ventricular fibrillation conversions of 4 attempts.

113 ominant frequency (13.0 versus 10.0 Hz), and ventricular fibrillation duration (160 versus 80 s) were

114 tion restitution (APDR) curve and can reduce ventricular fibrillation duration in failing ventricles.

115 A recent genome-wide association study of ventricular fibrillation during acute myocardial infarct

116 A heritable component in the risk of ventricular fibrillation during myocardial infarction ha

117 Induction of ventricular tachycardia/ventricular fibrillation during programmed ventricular s

118 on and then following 6 minutes of untreated ventricular fibrillation during sequential 5 minutes tre

119 eath, sustained ventricular tachycardia, and ventricular fibrillation either documented on ECG or rec

120 Multichannel ventricular fibrillation electrogram data from 7 isolate

121 =1 ICD-treated ventricular tachycardias (VT)/ventricular fibrillation episode, or a recorded, sustain

122 A total of 34 ventricular tachyarrhythmia/ventricular fibrillation episodes (20 induced; 14 sponta

123 ents with repetitive ventricular tachycardia/ventricular fibrillation episodes alternating with perio

124 Ventricular tachycardia and/or ventricular fibrillation episodes alternating with short

125 ysis retained ventricular tachycardia and/or ventricular fibrillation episodes alternating with short

126 cluded a median of 7 ventricular tachycardia/ventricular fibrillation episodes.

127 290 eligible patients with no arrhythmia or ventricular fibrillation/flutter (CL<200 ms) induced in

128 ducible ventricular tachycardia or inducible ventricular fibrillation/flutter) EPS result.

129 20 minutes of circulatory arrest, induced by ventricular fibrillation, followed by 6 hours of reperfu

130 ge-free survival for ventricular tachycardia/ventricular fibrillation >/= 240 beats per minute was eq

131 ociated with an increased risk of idiopathic ventricular fibrillation (ID-VF).

132 lly intact survival of patients with OHCA in ventricular fibrillation improved in 2 rural counties in

133 test RR interval </=250 ms) in 0% to 9%, and ventricular fibrillation in 0% to 2%, most of whom were

134 tole in 61.5% and ventricular tachycardia or ventricular fibrillation in 24.1%.

135 ge of 65 +/- 12 years, a previous history of ventricular fibrillation in 37% of the cases, and a mean

136 tely to terminate ventricular tachycardia or ventricular fibrillation in 43 of 224 patients (19%) ove

137 he breakup of spiral waves, which represents ventricular fibrillation in cardiac tissue.

138 During ventricular fibrillation in failing ventricles, the numb

139 Hypercholesterolemia protects against ventricular fibrillation in patients with myocardial inf

140 ts the recurrence of ventricular tachycardia/ventricular fibrillation in such patients.

141 s are critical in sustaining both atrial and ventricular fibrillation in the human heart and its impl

142 In contrast, in ventricular fibrillation in the setting of cardiac ische

143 ans, is believed to be a direct precursor of ventricular fibrillation in the whole heart.

144 hed reports of infants <3 months of age with ventricular fibrillation in which a primary diagnosis co

145 This is the first report of idiopathic ventricular fibrillation in young infants preceded by st

146 trict SCD hereafter to cardiac arrest due to ventricular fibrillation, including rhythms shockable by

147 During ischemia, ventricular tachycardia/ventricular fibrillation inducibility was larger in WT t

148 disappearance and no ventricular tachycardia/ventricular fibrillation inducibility without complicati

149 BrS ECG pattern, and ventricular tachycardia/ventricular fibrillation inducibility.

150 rdial substrate, and ventricular tachycardia/ventricular fibrillation inducibility.

151 A subset of MRI patients underwent ventricular fibrillation induction testing post-MRI to c

152 GS967 reduced ventricular fibrillation induction under a rapid pacing

153 inidine for atrial fibrillation who develops ventricular fibrillation is diagnosed with "acquired LQT

154 Understanding the mechanisms that drive ventricular fibrillation is essential for developing imp

155 tion testing by induction and termination of ventricular fibrillation is widely done at the time of i

156 After 15 mins of untreated ventricular fibrillation, isoflurane-anesthetized pigs r

157 Idiopathic ventricular fibrillation (IVF) is a rare cause of sudden

158 e genetic defect in a family with idiopathic ventricular fibrillation (IVF) manifesting in childhood

159 ent-elevation myocardial infarction, primary ventricular fibrillation, Killip class >=2 or TIMI (Thro

160 -55], lambda(d), 38%/ms [95% CI, 22-55]; rat ventricular fibrillation: lambda(f), 38%/ms+/-24 [95% CI

161 ator implantation without the need to induce ventricular fibrillation might eliminate the need for de

162 th out-of-hospital cardiac arrest (OHCA) and ventricular fibrillation, more than half present with re

163 on and included atrial fibrillation (n = 4), ventricular fibrillation (n = 6), supraventricular tachy

164 , (3) rat atrial fibrillation (n=4), (5) rat ventricular fibrillation (n=11), and (5) computer-simula

165 s, such as SCD (n=1), aborted SCD because of ventricular fibrillation (n=6), sustained ventricular ta

166 n = 36; polymorphic ventricular tachycardia/ventricular fibrillation, n = 14; other, n = 11), includ

167 ich a cluster of ventricular tachycardias or ventricular fibrillation, negatively affects short- and

168 al Center (MN, USA) with OHCA and refractory ventricular fibrillation, no return of spontaneous circu

169 Detection was set to ventricular fibrillation number of intervals to detect=2

170 16 events of polymorphic VT deteriorating to ventricular fibrillation) occurred in 23 (53%) patients.

171 the majority of SCD-ventricular tachycardia/ventricular fibrillation occurs in patients without know

172 ak troponin, prior MI, and presentation with ventricular fibrillation or cardiac arrest.

173 DE was associated with risk of VT/ventricular fibrillation or death (P=0.0032 for any DE a

174 associated with ventricular tachycardia (VT)/ventricular fibrillation or death in patients with cardi

175 guided group, but there was no difference in ventricular fibrillation or in total mortality between b

176 hospital cardiac arrest for shock-refractory ventricular fibrillation or pulseless ventricular tachyc

177 rdiac arrest due to initial shock-refractory ventricular fibrillation or pulseless ventricular tachyc

178 of-hospital cardiac arrest, shock-refractory ventricular fibrillation or pulseless ventricular tachyc

179 g and whose initial cardiac-arrest rhythm of ventricular fibrillation or pulseless ventricular tachyc

180 sudden cardiac death or nonfatal episode of ventricular fibrillation or sustained ventricular tachyc

181 ifekalant (NIF) are used in the treatment of ventricular fibrillation or tachycardia; however, only f

182 ned as arrhythmic death or ICD discharge for ventricular fibrillation or ventricular tachycardia >240

183 lantable cardiac defibrillator discharge for ventricular fibrillation or ventricular tachycardia >240

184 No inducible arrhythmia, ventricular fibrillation, or flutter (cycle length <200

185 th, ischemic stroke, ventricular tachycardia/ventricular fibrillation, or heart failure hospitalizati

186 ths who died due to ventricular tachycardia, ventricular fibrillation, or sudden unexpected death, or

187 aborted SCD (appropriate ICD shock, nonfatal ventricular fibrillation, or sustained ventricular tachy

188 d a better survival than those in refractory ventricular fibrillation (p = 0.017).

189 h was associated with early recurrence of VT/ventricular fibrillation (P=0.003) and ablation for elec

190 F hospitalization, HF death, and spontaneous ventricular fibrillation (P=0.028).

191 Clinical data in 5 idiopathic ventricular fibrillation patients suggested arrhythmia o

192 During ventricular fibrillation, peak I(m) was decreased by 50%

193 After 7 minutes of ventricular fibrillation, pigs were randomized to receiv

194 ardia (hazard ratio [HR]: 1.65, p < 0.0001), ventricular fibrillation/polymorphic ventricular tachyca

195 rm survival in patients with shock-resistant ventricular fibrillation /pulseless ventricular tachycar

196 om out-of-hospital cardiac arrest because of ventricular fibrillation, pulseless ventricular tachycar

197 ospital cardiac arrest from shock-refractory ventricular fibrillation/pulseless ventricular tachycard

198 al discharge in adults with shock-refractory ventricular fibrillation/pulseless ventricular tachycard

199 viduals presenting with shockable rhythms of ventricular fibrillation/pulseless ventricular tachycard

200 rm and long-term survival in shock-resistant ventricular fibrillation/pulseless ventricular tachycard

201 ockable rhythms evolve to shockable rhythms (ventricular fibrillation/pulseless ventricular tachycard

202 ntaneous episodes of ventricular tachycardia/ventricular fibrillation recorded in 21 patients (6.7%),

203 int of time to first ventricular tachycardia/ventricular fibrillation recurrence.

204 Only bileaflet MVP was associated with ventricular fibrillation recurrences requiring ICD thera

205 Resistant ventricular fibrillation, refibrillation.

206 icial circulation and defibrillation to halt ventricular fibrillation remain of paramount importance

207 5, PKP2-p.Arg79X, and the Chr7q36 idiopathic ventricular fibrillation risk haplotype) in a cohort of

208 diac death/sustained ventricular tachycardia/ventricular fibrillation (SCD/VT/VF).

209 tation for patients with OHCA and refractory ventricular fibrillation significantly improved survival

210 ccess was seen in 17 of 19 procedures, and a ventricular fibrillation storm occurred within 24 hours

211 eant for identifying atrial fibrillation and ventricular fibrillation substrate may allow us to recor

212 nsplantation, survived sudden cardiac death, ventricular fibrillation, sustained ventricular tachycar

213 13 of 24 patients (54%) received appropriate ventricular fibrillation-terminating ICD shocks.

214 BCE was defined as either (1) an appropriate ventricular fibrillation-terminating implantable cardiov

215 eizures, aborted cardiac arrest, appropriate ventricular fibrillation-terminating implantable cardiov

216 tion between pauses for all reasons and both ventricular fibrillation termination and patient surviva

217 d by chest compression fraction or decreased ventricular fibrillation termination rate.

218 Ventricular fibrillation termination was not the mechani

219 an IHCA caused by ventricular tachycardia or ventricular fibrillation, the rate of 1-year survival wa

220 When the simulated patient sustained ventricular fibrillation, the time required to report th

221 e more prevalent in patients with idiopathic ventricular fibrillation, their ability to predict cardi

222 cetylcholine analogue carbamylcholine raises ventricular fibrillation threshold (VFT) and flattens th

223 stable analogue of acetylcholine could raise ventricular fibrillation threshold (VFT), and whether th

224 Purkinje origin VE was identified as the ventricular fibrillation trigger in 6 of 6 cardiac arres

225 ar beats arising from the Purkinje tissue as ventricular fibrillation triggers have been documented b

226 hs, 230-740 ms, arrhythmic storm n=28) and 2 ventricular fibrillation triggers were targeted (25 tran

227 All but 6 of the 66 patients with inducible ventricular fibrillation underwent electrophysiological

228 tion, more than half present with refractory ventricular fibrillation unresponsive to initial standar

229 s and VA at index hospitalization, including ventricular fibrillation, ventricular tachycardia (VT),

230 ulmonary resuscitation 37%; initial rhythms: Ventricular fibrillation/ventricular tachycardia 24%, pu

231 in patients who undergo ECPR for refractory ventricular fibrillation/ventricular tachycardia out-of-

232 al in 160 consecutive adults with refractory ventricular fibrillation/ventricular tachycardia out-of-

233 t failure symptoms, shockable arrest rhythm (ventricular fibrillation/ventricular tachycardia), and S

234 fibrillation (AF) (n = 13), or scar-related ventricular fibrillation (VF) (n = 3) were examined.

235 he analysis of complex mechanisms underlying ventricular fibrillation (VF) and atrial fibrillation (A

236 ving documented ventricular tachycardia (VT)/ventricular fibrillation (VF) and Brugada syndrome-relat

237 erized a family presenting with a history of ventricular fibrillation (VF) and sudden death without e

238 ized that dantrolene improves survival after ventricular fibrillation (VF) by rectifying the calcium

239 the hypothesis that PH promotes spontaneous ventricular fibrillation (VF) during a critical post-PH

240 A comparative analysis of the ventricular fibrillation (VF) dynamics for every heart w

241 Quantitative measures of the ventricular fibrillation (VF) ECG waveform can assess my

242 Spontaneous ventricular tachyarrhythmia (VT)/ventricular fibrillation (VF) events (n=111) were treate

243 endocardial activation during long-duration ventricular fibrillation (VF) exhibits organized activit

244 Ventricular fibrillation (VF) has been proposed to be ma

245 n (APD) shortening and recurrent spontaneous ventricular fibrillation (VF) in failing ventricles.

246 Studies of ventricular fibrillation (VF) in humans are limited beca

247 incidence of ventricular tachycardia (VT) or ventricular fibrillation (VF) in patients with heart fai

248 tested the hypothesis that ischemia-induced ventricular fibrillation (VF) is facilitated by platelet

249 VT) have been described, but their impact on ventricular fibrillation (VF) is largely unknown.

250 Ventricular fibrillation (VF) optical mapping was perfor

251 e the percentage of patients who experienced ventricular fibrillation (VF) or potentially malignant a

252 l cardiac arrest has raised the concern that ventricular fibrillation (VF) recurrence may be triggere

253 Reperfusion-induced ventricular fibrillation (VF) severely threatens the liv

254 This study mapped human ventricular fibrillation (VF) to define mechanistic diff

255 ess the feasibility of terminating sustained ventricular fibrillation (VF) via light-induced excitati

256 Ventricular fibrillation (VF) waveform properties have b

257 D) or sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) with appropriate ICD thera

258 After defibrillation of initial ventricular fibrillation (VF), it is crucial to prevent

259 aimed to study whether AF is associated with ventricular fibrillation (VF), the most common cause of

260 eart can lead to cardiac arrhythmias such as ventricular fibrillation (VF), which in turn compromise

261 intended for prevention of ischaemia-induced ventricular fibrillation (VF).

262 permits therapy for ventricular tachycardia/ventricular fibrillation (VF).

263 roved defibrillation techniques to terminate ventricular fibrillation (VF).

264 e ventricular excitation (PVEM) and, rarely, ventricular fibrillation (VF).

265 ced ICD-treated ventricular tachycardia (VT)/ventricular fibrillation (VF).

266 first clinic visit were analyzed to predict ventricular fibrillation (VF)/SCD during follow-up.

267 atients with refractory out-of-hospital (OH) ventricular fibrillation (VF)/ventricular tachycardia (V

268 A are associated with conduction disease and ventricular fibrillation (VF); however, the mechanisms t

269 omyopathy (HCM), and ventricular tachycardia-ventricular fibrillation (VT-VF).

270 thms of ventricular tachycardia or pulseless ventricular fibrillation (VT/VF).

271 fraction, including ventricular tachycardia/ventricular fibrillation (VT/VF).

272 py to pacing-induced ventricular tachycardia/ventricular fibrillation (VT/VF).

273 tricular arrhythmia (ventricular tachycardia/ventricular fibrillation [VT/VF]), stage C heart failure

274 ad premature ventricular contraction-induced ventricular fibrillation/VT (29%), and VT could not be i

275 th initial rhythm of ventricular tachycardia/ventricular fibrillation was 56%, of whom 82 had a compl

276 Inducibility of ventricular tachycardia/ventricular fibrillation was associated with an increase

277 or IHCA caused by ventricular tachycardia or ventricular fibrillation was associated with higher rate

278 Ventricular fibrillation was electrically induced in 30

279 illation in patients who were found to be in ventricular fibrillation was included in the propensity

280 Ventricular fibrillation was induced in 30 male domestic

281 Ventricular fibrillation was induced in 66 patients, inc

282 Ventricular fibrillation was induced in 9 of 12 CKD rats

283 Ventricular fibrillation was induced, and defibrillation

284 ts (group II), where ventricular tachycardia/ventricular fibrillation was not induced.

285 arge diagnosis of ventricular tachycardia or ventricular fibrillation was performed.

286 rate terminating ventricular tachycardia or ventricular fibrillation was the same in patients who un

287 Ventricular tachycardia/ventricular fibrillation was triggered in 44 patients (g

288 ricular tachycardia (VT) >/=240 beats/min or ventricular fibrillation, was a younger age at enrollmen

289 zed by renin and norepinephrine overflow and ventricular fibrillation, was potentiated ( approximatel

290 r ICD discharges for ventricular tachycardia/ventricular fibrillation were equivalent to an aborted d

291 Two patterns of onset of ventricular fibrillation were observed and were reproduc

292 used by pulseless ventricular tachycardia or ventricular fibrillation were stratified by prompt (</=2

293 Episodes of ventricular fibrillation were uniformly successfully tre

294 efibrillation for ventricular tachycardia or ventricular fibrillation) were analyzed with multivariat

295 illation: A Validation on 1617 Patients With Ventricular Fibrillation," which was published in the Fe

296 ss electrical activity/asystole or resistant ventricular fibrillation who were treated with mild ther

297 ttempted to defibrillate after 10 seconds of ventricular fibrillation with a single approximately 30-

298 After prolonged ventricular tachycardia/ventricular fibrillation without resuscitation, asystole

299 tachycardia zone) and at rates >/= 200 bpm (ventricular fibrillation zone).

300 adjusted) in the VT zone, and 6 of 10 in the ventricular fibrillation zone.